← Back to headlines
AstraZeneca's Hypertension Drug Baxfendy Receives US FDA Approval
AstraZeneca has announced that its hypertension drug, Baxfendy, has received approval from the U.S. Food and Drug Administration (FDA). This approval marks a significant step for the treatment of hypertension.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
North Macedonia Reports Fourth West Nile Virus Death, Skopje Declared Epidemic Zone
23m ago
Jamal Musiala Addresses On-Pitch Collapses, Cites Neurological Dysfunction
26m ago
Common Beverages Often Contain More Sugar Than a Glazed Donut
2h ago
Blood Test for Cancer Recurrence Could Be Implemented in Years
3h ago